Cargando…
Potent Anti-Tumor Effect Generated by a Novel Human Papillomavirus (HPV) Antagonist Peptide Reactivating the pRb/E2F Pathway
Human papillomavirus type 16 (HPV16) E7 is a viral oncoprotein believed to play a major role in cervical cancer. In this study, an antagonist peptide against HPV16E7 protein was first identified from screening the c7c phage display peptide library. The binding specificity and affinity of the selecte...
Autores principales: | Guo, Cai-ping, Liu, Ke-wei, Luo, Hai-bo, Chen, Hong-bo, Zheng, Yi, Sun, Shen-nan, Zhang, Qian, Huang, Laiqiang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057995/ https://www.ncbi.nlm.nih.gov/pubmed/21423621 http://dx.doi.org/10.1371/journal.pone.0017734 |
Ejemplares similares
-
Treating cancer when pRb and p53 cannot be reactivated
por: Zhu, Liang
Publicado: (2015) -
Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling
por: Buitrago-Pérez, Águeda, et al.
Publicado: (2009) -
Relevance of pRB Loss in Human Malignancies
por: Mandigo, Amy C., et al.
Publicado: (2022) -
CDK4, pRB and E2F1: connected to insulin
por: Fajas, Lluis, et al.
Publicado: (2010) -
Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN‐amplified retinoblastoma
por: Ewens, Kathryn G., et al.
Publicado: (2017)